Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

News

Promoting Health and Recovery: Daily Care for Leukemia Patients

Promoting Health and Recovery: Daily Care for Leukemia Patients

2024-07-03

Ensuring a safe and comfortable treatment experience for leukemia patients involves meticulous daily care, including environmental sanitation, personal hygiene, nutrition, and appropriate exercise. This guide provides essential tips for effective daily care to support recovery.

view detail
NS7CAR-T Cell Therapy Shows Promise for Treating R/R T-ALL/LBL

NS7CAR-T Cell Therapy Shows Promise for Treating R/R T-ALL/LBL

2024-06-20

A recent study highlights the efficacy and safety of NS7CAR-T cell therapy in treating relapsed or refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) and T-cell lymphoblastic lymphoma (R/R T-LBL). This therapy offers new hope for patients with these aggressive forms of cancer.

view detail
Groundbreaking Results of CD7-Targeted CAR-T Therapy for T-ALL and T-LBL

Groundbreaking Results of CD7-Targeted CAR-T Therapy for T-ALL and T-LBL

2024-06-18

A recent study highlights the promising results of CD7-targeted chimeric antigen receptor (CAR) T cell therapy in treating patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL).

view detail
Coverage of the 2024 ASH Annual Meeting and Exposition

Coverage of the 2024 ASH Annual Meeting and Exposition

2024-06-13

The 66th Annual Meeting of the American Society of Hematology (ASH) will be held from December 7-10, 2024, at the San Diego Convention Center, showcasing groundbreaking research and advancements in hematology.

view detail
Announcing the 2024 Annual Lu Daopei Hematology Forum in August

Announcing the 2024 Annual Lu Daopei Hematology Forum in August

2024-06-11

The 12th Annual Lu Daopei Hematology Forum is set to take place on August 23-24, 2024, at the Beijing International Convention Center. Join us for insightful discussions and the latest advancements in hematology.

view detail
New Hope in Cancer Treatment: TILs Therapy Emerges as the Next Frontier

New Hope in Cancer Treatment: TILs Therapy Emerges as the Next Frontier

2024-06-05

Despite the ongoing challenges in industrialization and commercialization, CAR-T therapy's limitations are being addressed by a promising new approach: Tumor-Infiltrating Lymphocyte (TIL) therapy. This breakthrough heralds a new era in the fight against solid tumors.

view detail

Are Cellular Therapies the Future of Autoimmune Disease?

2024-04-30

A revolutionary treatment for cancers may also be able to treat and reset the immune system to provide long-term remission or possibly even cure certain autoimmune diseases.

view detail
2023 ASH Opening | Dr. Peihua Lu Presents CAR-T for Relapsed /Refractory AML Research

2023 ASH Opening | Dr. Peihua Lu Presents CAR-T for Relapsed /Refractory AML Research

2024-04-09
A phase I clinical study of CD7 CAR-T for R/R AML by Daopei Lu's team debuts at ASHThe 65th Annual Meeting of the American Society of Hematology (ASH) was held offline (San Diego, USA) and online on December 9-12, 2023.Our scholars made a great show of this co...
view detail
ASH 2023|"The Voice of Lu Daopei" sings on the international stage

ASH 2023|"The Voice of Lu Daopei" sings on the international stage

2024-04-09
The American Society of Hematology (ASH) is the top academic meeting in the field of haematology worldwide. The fact that Lu Daopei Hospital has been selected as a finalist for the ASH for consecutive years fully demonstrates its academic achievements in the f...
view detail
ASH Voice of China| Professor Xian Zhang: High Efficacy And Safety of Nanobody Based Anti-BCMA CAR-T Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

ASH Voice of China| Professor Xian Zhang: High Efficacy And Safety of Nanobody Based Anti-BCMA CAR-T Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

2024-04-09
The 65th Annual Meeting of the American Society of Hematology (ASH) was held from 9 to 12 December 2023, in San Diego, USA. As the world's largest and most comprehensive hematology top academic event, it attracts thousands of experts and scholars from all over...
view detail